» Articles » PMID: 10446812

Common Regions of Deletion on Chromosome 22q12.3-q13.1 and 22q13.2 in Human Astrocytomas Appear Related to Malignancy Grade

Overview
Specialties Neurology
Pathology
Date 1999 Aug 14
PMID 10446812
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately 30% of human astrocytomas have been reported to display allelic loss of the long arm of chromosome 22, suggesting the presence of a chromosome 22q astrocytoma suppressor gene. To define the most likely location for this putative tumor suppressor, we performed deletion mapping on 141 tumors using 16 chromosome 22q microsatellite markers. Allelic loss of 22q was observed in 2/12 (17%) of astrocytomas, 9/29 (31%) of anaplastic astrocytomas, and 38/100 (38%) of glioblastomas, consistent with a role for chromosome 22q loss in astrocytoma progression as well as formation. Twenty-two tumors exhibited allelic loss at every informative locus, consistent with loss of the entire arm of 22q. Twenty-seven tumors showed partial deletions, with one common region of deletion at 22q12.3-q13.1 between markers D22S280 and D22S282, and a second candidate region at 22q13.2 near the marker D22S1170. For the proximal candidate region, the incidence of allelic loss was similar between grades; for the distal locus, the incidence increased with grade, raising the possibility that the distal locus is involved in a later stage of astrocytoma tumorigenesis.

Citing Articles

Tissue inhibitor of matrix metalloproteinase-3 has both anti-metastatic and anti-tumourigenic properties.

Rai G, Baird S Clin Exp Metastasis. 2020; 37(1):69-76.

PMID: 31894441 DOI: 10.1007/s10585-019-10017-y.


Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.

Schulze M, Fedorchenko O, Zink T, Knobbe-Thomsen C, Kraus S, Schwinn S Oncogene. 2015; 35(24):3163-77.

PMID: 26549022 DOI: 10.1038/onc.2015.376.


Pannexin2 oligomers localize in the membranes of endosomal vesicles in mammalian cells while Pannexin1 channels traffic to the plasma membrane.

Boassa D, Nguyen P, Hu J, Ellisman M, Sosinsky G Front Cell Neurosci. 2015; 8:468.

PMID: 25698922 PMC: 4313697. DOI: 10.3389/fncel.2014.00468.


Tumor prognostic factors and the challenge of developing predictive factors.

Holliday E, Sulman E Curr Oncol Rep. 2012; 15(1):33-46.

PMID: 23224629 DOI: 10.1007/s11912-012-0283-3.


Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH.

Talagas M, Marcorelles P, Uguen A, Redon S, Quintin-Roue I, Costa S J Neurooncol. 2012; 109(2):405-13.

PMID: 22825724 DOI: 10.1007/s11060-012-0909-1.